Effect of BIIL 284 BS on Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT02249338 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

53

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: BIIL 284 BS
DRUG: Placebo

Sponsor

Boehringer Ingelheim